Introduction
The treatment of hemothorax depends on the amount of blood in the pleural space, the rate of bleeding, and whether the bleeding has stopped. The main approaches are observation, oxygen and fluid support, chest tube drainage, blood transfusion when needed, and surgery for ongoing or retained bleeding. These treatments work by removing blood from around the lung, restoring normal pressure and lung expansion, stabilizing circulation, and controlling the source of hemorrhage. In this way, treatment addresses both the mechanical effects of blood in the chest and the physiologic consequences of blood loss.
Understanding the Treatment Goals
Hemothorax is the accumulation of blood between the visceral and parietal pleura. Blood in this space compresses the lung, reduces tidal expansion, and can impair gas exchange by preventing normal ventilation of the affected side. If the blood loss is large enough, the patient can also develop hypovolemia and shock. Treatment is therefore directed at two parallel problems: the local problem of lung compression and the systemic problem of hemorrhage.
The main goals are to reduce respiratory symptoms, restore lung expansion, stop ongoing bleeding, and prevent later complications such as infection, fibrothorax, and trapped lung. These goals determine whether treatment can be conservative or whether drainage and surgical intervention are needed. A small, stable hemothorax may resolve with close observation, while a large or rapidly expanding one requires active removal of blood and control of the bleeding source.
Common Medical Treatments
Supplemental oxygen is often used when oxygenation is reduced. Oxygen does not remove blood from the pleural space, but it increases the fraction of inspired oxygen, which improves diffusion into the bloodstream from the remaining ventilated lung tissue. This helps offset the mismatch between ventilation and perfusion caused by lung compression.
Intravenous fluids may be given to support circulating volume when blood loss is significant. Their role is to temporarily maintain preload and blood pressure, preserving organ perfusion while definitive control of hemorrhage is arranged. Crystalloid fluids do not replace red blood cells, so they correct only part of the physiologic deficit.
Blood transfusion is used when hemothorax causes major blood loss or hemodynamic instability. Packed red blood cells restore oxygen-carrying capacity by replacing hemoglobin, which supports tissue oxygen delivery after hemorrhage. In severe bleeding, transfusion may also include plasma or platelets to address dilutional coagulopathy and help preserve clotting function.
Pain control is frequently needed because pleural blood and chest trauma can produce substantial pain. Analgesia reduces splinting, allowing deeper breaths and better ventilation. This lowers the risk of atelectasis, in which collapsed alveoli form when the patient avoids full expansion because of pain.
Procedures or Interventions
Tube thoracostomy, or chest tube placement, is the most common procedural treatment for clinically significant hemothorax. A tube is inserted into the pleural space to drain liquid blood and prevent further accumulation. Removing blood reduces pressure on the lung, allowing the elastic recoil of the chest wall and lung to re-expand the compressed tissue. Drainage also helps distinguish active bleeding from residual clotting by measuring the output over time.
Chest tube drainage is especially important when the collection is large, when breathing is impaired, or when blood is likely to clot and remain trapped. Once the blood is evacuated, the pleural surfaces can reapproximate, which improves mechanics of respiration and reduces the inflammatory stimulus that contributes to scarring.
Surgical intervention is used when bleeding continues despite drainage, when a major vessel or lung injury is suspected, or when retained clot cannot be cleared by a tube alone. In trauma, this may involve video-assisted thoracoscopic surgery or open thoracotomy. Surgery works by directly identifying and controlling the bleeding source, removing clotted blood, and restoring normal pleural anatomy.
In a retained hemothorax, blood has partially clotted in the pleural space and can no longer drain effectively through a tube. This retained material acts as a foreign body, sustaining inflammation and increasing the risk of empyema and fibrotic pleural peel formation. Thoracoscopic evacuation removes the clot before organization and scarring become established.
In some cases, interventional radiology may be used to embolize a bleeding vessel. This approach blocks arterial flow to the injured vessel, reducing or stopping hemorrhage without open surgery. It is useful when the bleeding source is identifiable and accessible through catheter-based techniques.
Supportive or Long-Term Management Approaches
After initial treatment, management focuses on recovery of lung function and detection of delayed complications. Follow-up imaging is commonly used to confirm that the pleural space is clearing and that no retained collection remains. This monitoring matters because clotted blood can persist even when immediate symptoms improve, and delayed retention can interfere with lung expansion.
Respiratory support measures, including assisted coughing and lung expansion exercises in many clinical settings, help maintain alveolar inflation after drainage. The physiologic aim is to reverse shallow breathing patterns and prevent collapse of air sacs, which can occur when the lung has been compressed for a prolonged period.
Ongoing management also includes observation for infection, especially if blood remains in the pleural space. Blood is a nutrient-rich medium that can support bacterial growth, so unresolved collections raise the risk of empyema. If inflammation progresses, fibrous tissue may form over the lung surface, limiting full expansion and producing restrictive impairment.
When hemothorax results from trauma or a coagulation disorder, longer-term treatment may involve addressing the underlying cause, such as correcting clotting abnormalities or managing associated injuries. Treating the root cause reduces the chance of recurrent bleeding into the pleural space.
Factors That Influence Treatment Choices
Severity is the most important determinant. A small, stable hemothorax with no evidence of active bleeding may be managed conservatively because the body can sometimes reabsorb limited pleural blood over time. A large hemothorax, by contrast, usually requires drainage because the mechanical compression is too great for spontaneous resolution.
The stage of the collection also matters. Fresh liquid blood drains more easily than organized clot. Once blood coagulates and becomes loculated, a simple tube may not evacuate it effectively, making surgical removal more likely. This is one reason early treatment can be easier and more effective than delayed treatment.
Age and overall health influence tolerance of blood loss and lung compression. People with reduced cardiopulmonary reserve may develop symptoms with smaller collections because they have less physiologic reserve to compensate for impaired ventilation or circulating volume loss. Underlying disorders such as anticoagulant use, platelet dysfunction, or lung disease can also shift treatment toward more aggressive monitoring and correction of the contributing problem.
Response to initial therapy is another major factor. If chest tube output decreases and imaging shows lung re-expansion, treatment can often continue conservatively. Persistent bleeding, failure of lung re-expansion, or signs of retained clot indicate that the pleural space has not been adequately cleared or that the hemorrhage source remains active.
Potential Risks or Limitations of Treatment
Observation alone carries the risk that blood will remain in the pleural space long enough to clot and organize. Once organized, the collection can become difficult to remove and may lead to pleural fibrosis. The limitation of conservative care is that it assumes bleeding has stopped and that the collection is small enough not to impair function significantly.
Chest tube drainage can be incomplete if blood has already clotted or if the tube is blocked by thick material. In addition, drainage itself can cause pain, local injury, or infection. Rapid decompression is usually beneficial, but persistent air or fluid leaks may complicate recovery if the underlying tissue injury has not sealed.
Transfusion and fluid resuscitation address circulation, but they do not stop bleeding. If used without control of the source, they may temporarily improve hemodynamics while the hemothorax continues to enlarge. Transfusion also carries standard risks related to immune reactions, volume overload, and coagulation disturbance.
Surgery and invasive procedures are effective when necessary, but they introduce risks of anesthesia, postoperative pain, infection, and injury to surrounding structures. Their main limitation is that they are more resource-intensive and are generally reserved for cases where the benefit of clearing the pleural space or controlling hemorrhage outweighs procedural risk.
Conclusion
Hemothorax is treated by combining physiologic support with mechanical removal of blood and control of the bleeding source. Small stable collections may resolve with observation, while more significant cases require oxygen, transfusion, chest tube drainage, or surgery. These treatments work by restoring lung expansion, correcting impaired gas exchange, preserving circulating volume, and preventing clot organization and pleural scarring. The choice of treatment depends on the size of the hemothorax, whether bleeding is ongoing, how much the lung is compressed, and the patient’s overall clinical condition. In every case, the treatment strategy is aimed at reversing the effects of blood in the pleural space and preventing the cascade of respiratory and inflammatory complications that can follow.